How are Regulatory Guidelines Evolving to Support MRD as a Diagnostic Tool, Implementable in the Clinic?
Time: 10:00 am
Details:
• The FNIH supports public health and the mission of the NIH through public private research partnerships, and Biomarkers Consortium projects bridge the gap between basic research and practical needs for advancing drug development and regulatory science
• The FNIH ctDNA QCM project will provide quality control materials that will help real-world users to develop ctDNA assays and monitor their performance
• The FNIH joins organizations that recognize the importance of working towards the global use of liquid biopsy and common reference standards in oncology in the International Liquid Biopsy Standardization Alliance to promote their use in the broader medical community
